Introduction
The diagnosis of Behçet's disease was based on the criteria of the International Study Group. The patients with one or more
The pathergy test is important in the diagnosis of Behçet's symptoms of the disease were said to be in the ''active period, '' disease. 1,2 Currently, it is applied with disposable/sharp while patients with no symptoms, but in whom the disease had needles and evaluated only clinically (no histopathologic been diagnosed before, were considered to be in the evaluation).
''remission period.'' The number of patients in the active and
In this study, the usefulness of the pathergy test conducted remission periods were 32 and 11, respectively.
intradermally (ID) and intravenously (IV) with disposable/
In the selection of the control group, it was important to sharp needles for the diagnosis and determination of the exclude patients with clinical findings related to Behçet's activation of the disease is studied in comparison with disease and certain diseases such as pyoderma gangrenosum the test conducted with nondisposable/blunt needles. In and erythema elevatum diutinum for which the pathergy addition, histopathologic evaluation of the pathergy test is reaction is positive.
compared with the clinical evaluation.
The pathergy test was applied to Behçet's disease patients and the control group ID and IV with disposable/sharp and Methodology nondisposable/blunt needles. The results were evaluated clinically and histopathologically. The patients and the control Forty-three Behçet's disease patients, of whom 24 were group did not use colchicine, steroids, or nonsteroidal antiwomen, who visited our clinic between April 1996 and June inflammatory drugs for at least 1 week before the test. Blunt 1997, were included in the study. Fifteen patients with and sharp needles of type 20G ϭ No. 1 were used in the tests. dermatosis, of whom seven were women, were selected as the Disposable/sharp needles were applied to the right arm, control group. The average ages of the Behçet's disease whereas nondisposable/blunt needles were applied to the left patients and the control group were 32.8 and 33.1 years, respectively.
arm. Hairless and avascular regions in the flexor parts of both 
Clinical results
The positivity results of the ID and IV applications of the infiltration, thickening of blood vessels, and erythrocyte extravasation are found to be statistically higher in the pathergy test with nondisposable/blunt and disposable/ sharp needles on the Behçet's disease patients and the patients than in the control group (P ϭ 0.01, P Ͻ 0.01, and P Ͻ 0.01, respectively). Vasculitis is seen only in control group are depicted in Table 1 .
When ID and IV applications are compared, the positivity three cases. When the positive and negative test results with nondisof ID tests with nondisposable/blunt needles applied to patients in both active and remission periods is found to posable/blunt needles for active and remission period patients are compared, for both active and remission be statistically higher (with P Ͻ 0.01 and P ϭ 0.05, respectively). The test results obtained with disposable/ period patients with positive pathergy, perivascular lymphohistiocytic infiltration, blood vessel thickening, and sharp needles on the active period patients are found to be statistically no different (P Ͼ 0.10). No positivity is erythrocyte extravasation, and the coexistence of these three symptoms, which indicate blood vessel damage, are observed with disposable/sharp needles for the remission period patients. ID and IV test results with disposable/ found to be statistically higher (P Ͻ 0.01, P Ͻ 0.01, P ϭ 0.04, and P Ͻ 0.01, respectively). When positive and sharp and nondisposable/blunt needles in the control group are all negative.
negative test results with disposable/sharp needles are compared, in the active period patients with positive results, When active and remission periods are compared, the positivity of ID and IV tests with nondisposable/blunt perivascular lymphohistiocytic infiltration, blood vessel thickening, acanthosis in the epidermis, and focal neutroneedles is found to be statistically higher in the active period patients (with P ϭ 0.02 and P ϭ 0.05, respectively).
phil infiltration in the dermis are found to be statistically higher (P ϭ 0.02, P ϭ 0.03, P ϭ 0.03, and P Ͻ 0.00, When active and remission period patients are compared with the control group, the positivity of ID and IV tests respectively). As there is no positive reaction to disposable/ sharp needles in remission period patients, no comparison with nondisposable/blunt needles in active period patients and the positivity of the ID test with nondisposable/blunt is made. When pathergy test results with nondisposable/blunt and needles in the remission period patients are found to be statistically higher than in the control group (with P Ͻ 0.01, disposable/sharp needles are compared for the active and remission period patients, blood vessel thickening, P Ͻ 0.01, and P Ͻ 0.01, respectively). The positivity of the IV test with nondisposable/blunt needles in the remission erythrocyte extravasation, and acanthosis density in the epidermis in both groups of patients, and perivascular period patients is found to be statistically no different than that of the control group (P Ͼ 0.10). No statistical lymphohistiocytic infiltration in active period patients, are found to be statistically higher for nondisposable/blunt extravasation is found to be statistically higher in the active period patients with nondisposable/blunt needles (P ϭ needles (P Ͻ 0.01, P Ͻ 0.01, P ϭ 0.05, P ϭ 0.04, P ϭ 0.02, P ϭ 0.02, and P Ͻ 0.01, respectively). For both 0.005). No statistically significant difference is observed between the other findings. active and remission period patients, the coexistence of findings indicating blood vessel damage is statistically higher with nondisposable/blunt needles (P Ͻ 0.01 and Discussion P Ͻ 0.01, respectively). Lymphocytic-type vasculitis is seen in two of the positive pathergy tests with nondisposable/ The positivity rate of the pathergy test in Behçet's disease varies for different countries. Controlled studies in Turkey blunt needles, whereas it is observed in one of the negative pathergy tests with nondisposable/blunt needles.
have shown that the positivity rate ranges from 72% to 98%; 3-5 however, the positivity rate reported in studies No vasculitis is found in the tests with disposable/sharp needles. No positive pathergy reaction is observed in the carried out after 1986 has decreased. This decrease is associated with the wide use of disposable/sharp needles control group.
When paired histopathologic comparison is conducted to protect against certain diseases, such as acquired immunodeficiency syndrome (AIDS) and hepatitis B. The between the active and remission period patients with positive and negative pathergy results for both noninsignificance of a positive pathergy test in the diagnosis of Behçet's disease in developed countries may be explained disposable/blunt and disposable/sharp needles, no statistically significant difference is observed between them by the fact that disposable/sharp needles have been used for a comparatively longer period of time. 6-9 (P Ͼ 0.05).
When the active and remission period patients are comIn order for a pathergy reaction to occur, the needle must reach the dermis. 4,10,11 Dilşen et al. 6 concluded that pared for the incidence of the coexistence of perivascular lymphohistiocytic infiltration, blood vessel thickening, and the positivity rate attained by nondisposable/blunt needles was statistically higher than the rate attained by disposable/ erythrocyte extravasation, which indicate blood vessel damage, no statistically significant difference is observed sharp needles when both needles were used on the same patients. This conclusion can be explained by the fact that (P Ͼ 0.05).
As no pathergy positivity with both nondisposable/blunt calcium accumulation occurs at the tip of nondisposable/ blunt needles when they are sterilized in boiling water, and disposable/sharp needles is obtained in the control group, the control group is not compared with the active and hence they become more traumatic than disposable/ sharp needles. 9 and remission period patients. When the negative pathergy with nondisposable/blunt needles is compared with There is no standardized method for conducting the pathergy test. ID, IV, and subcutaneous (SC) applications disposable/sharp needles histopathologically, erythrocyte of the test are used. There is no generally accepted opinion are evaluated, the number of histopathologic findings of vascular inflammation obtained with nondisposable/blunt on which form of the test yields a higher positivity rate. 3, 10 In this study, the positivity rate yielded by the ID needles is statistically higher than that with disposable/ sharp needles. This result also shows that nondisposable/ application of nondisposable/blunt needles is found to be statistically higher than that by IV application in both blunt needles are superior to disposable/sharp needles in the histopathologic pathergy test. active and remission period patients. In addition, ID and IV applications of nondisposable/blunt needles in active Recently, histopathologic and immunopathologic evaluation of the test, instead of clinical evaluation, has period patients and ID application of nondisposable/blunt needles in remission period patients yield statistically higher been recommended by some researchers to increase its sensitivity. 15 When a paired comparison of positive and positivity rates than in the control group. These results suggest that the use of disposable/sharp needles is insuffinegative pathergy test results conducted with nondisposable/blunt and disposable/sharp needles in active cient in the pathergy test, and that the test should be carried out ID with nondisposable/blunt needles.
and remission period patients is made histopathologically, The pathergy test yields positive results for active period no statistically significant difference is observed between patients, whereas it yields either positive or negative results the pathergy test results. In our study, when clinically for remission period patients. 1,2 In our study, the positivity obtained positive and negative pathergy test results conrates of both ID and IV applications of nondisposable/ ducted with nondisposable/blunt and disposable/sharp blunt needles in active period patients are statistically needles in active and remission period patients are comhigher than those in remission period patients. This result pared with the histopathologic results, it is observed that suggests that the pathergy test with nondisposable/blunt the pathergy test results obtained with nondisposable/blunt needles may be a benchmark in determining the activity needles, which are clinically negative, are also found to be level of the disease. It also suggests that the test with histopathologically negative. disposable/sharp needles is insufficient for both the The results of our study suggest that the clinical evaluadiagnosis and follow-up of the disease.
tion of the pathergy test conducted ID with nondisposable/ Different histopathologic results related to the pathergy blunt needles is sufficient both for the diagnosis and test have been reported in various studies. Haim et al., 12, 13 determination of the activation of Behçet's disease. Morefor example, have reported lymphocyte and plasma cell over, the histopathologic evaluation of the test is not found infiltration with varying densities in perivascular and to be more sensitive than the clinical evaluation. periadnexal locations, and sometimes small neutrophil sets in biopsies taken 24 h after the test.; however, they have not reported any pathology in blood vessels. In a study by References Sobel et al., 14 sharp needles in active and remission period patients
